⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 20, 2024Journal of neurology & translational neuroscience.Open Access

Salivary Alpha-Synuclein to Differentiate Parkinson’s Disease from Drug Induced Parkinsonism and Controls Using ELISA

Cécile Aerts Christophe Hirtz Victoria González Teodora Parvu Marie De Verdal Valérie Cochen De Cock E. Moulis Pascale Fabbro-Péray Sylvain Lehmann Sandrine Alonso Giovanni Castelnovo

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Background: Alpha-synuclein is a promising biomarker for Parkinson’s disease (PD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Aerts et al. (2024) studied this question.

synapsesocial.com/papers/68e6e50db6db643587660d81 https://doi.org/10.47739/2333-7087.neuroscience.1094

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Alpha-Synuclein Strains in Plasma Distinguish Parkinson’s Disease from Dementia with Lewy Bodies (S26.006)2024 · 1 citations
2A Surface Imprinted Polymer EIS Sensor for Detecting Alpha-Synuclein, a Parkinson’s Disease Biomarker2024 · 16 citations
3Evaluating the Diagnostic Potential of Combined Salivary and Skin Biomarkers in Parkinson’s Disease2024 · 10 citations
4Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome2024 · 3 citations
5α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders2024 · 45 citations